Xanax®, when prescribed and taken as indicated in accordance with the FDA approved product package insert, has a well established safety profile and is a treatment option that has benefitted millions of patients.
It is imperative that prescribers who are treating patients with Xanax are aware of its risks and communicate them to patients – before prescribing the product and during the course of the patient’s treatment.
Under no circumstances does Pfizer condone the misuse or abuse of our products.
